A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 20, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Oct 29, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MYE SEC filings page.
Myers Industries, Inc. (MYE) reported $857.5M in revenue over the twelve months to Sep 30, 2026, up 24.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue is flat, but FY2025 profit and cash recovered as the company worked through a debt-heavy balance-sheet expansion.
The FY2025 earnings rebound was not volume-led: revenue fell1.3% while operating income rose67.6% , pointing to margin recovery rather than stronger demand. Lower interest expense also helped, yet the larger driver was operating improvement, since net income rose385.0% after collapsing in FY2024.
FY2024 materially changed the financing model: assets expanded
FY2025 cash generation was stronger than accounting profit alone suggests: operating cash flow reached
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Myers Industries, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. Myers Industries, Inc. scores 63/100 on it among other operating companies.
Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. Myers Industries, Inc. scores 33/100 on it among other operating companies.
Myers Industries, Inc.'s net debt of $270.7M, being $311.2M of long-term debt less $40.5M of cash, came to 2.94 times its EBITDA in fiscal year 2025. Operating companies are ranked here on long-term debt less cash against their EBITDA, where a lower multiple is the safer one, and Myers Industries, Inc. scores 30/100 among other operating companies measured the same way.
Myers Industries, Inc. held $1.67 of current assets for every $1 of current liabilities at the end of fiscal year 2025, a current ratio of 1.67. Liquidity ranks operating companies on that ratio, and Myers Industries, Inc. scores 49/100 among other operating companies.
Cash Flow ranks operating companies on their free cash flow margin, which is operating cash flow less capital spending as a share of revenue, averaged over the last three fiscal years with the newest weighted most. Myers Industries, Inc. scores 57/100 on it among other operating companies.
Returns ranks operating companies on their return on capital employed, which is operating income against total assets less current liabilities, averaged over three fiscal years with the newest weighted most, and in smaller part on how steady that return has been. Myers Industries, Inc. scores 68/100 on it among other operating companies.
Myers Industries, Inc. scores 2.41, placing it in the grey zone between 1.81 and 2.99. The largest contribution to the score comes from a market capitalization of $976.7M against total liabilities of $558.4M. This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Myers Industries, Inc. passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.
For every $1 of reported earnings, Myers Industries, Inc. generates $2.48 in operating cash flow ($86.8M OCF vs $34.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Myers Industries, Inc. earns $2.53 in operating income for every $1 of interest expense ($74.6M vs $29.4M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.
Key Financial Metrics
Earnings & Revenue
Myers Industries, Inc. generated $171.3M in revenue in Q3 2026. This represents an increase of 8.1% from the same quarter a year earlier. Against the prior quarter it is down 4.4%.
Myers Industries, Inc.'s EBITDA was $18.4M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 12.7% from the same quarter a year earlier. Against the prior quarter it is down 47.3%.
Myers Industries, Inc. reported a net loss of $865K in Q3 2026. This represents a decrease of 112.2% from the same quarter a year earlier. Against the prior quarter it is down 104.3%.
Myers Industries, Inc. earned -$0.02 per diluted share (EPS) in Q3 2026. This represents a decrease of 110.5% from the same quarter a year earlier. Against the prior quarter it is down 103.8%.
Cash & Balance Sheet
Myers Industries, Inc. generated $11.1M in free cash flow in Q3 2026, representing cash available after capex. This represents a decrease of 48.5% from the same quarter a year earlier. Against the prior quarter it is down 60.2%.
Myers Industries, Inc. held $53.5M in cash against $279.6M in long-term debt as of Q3 2026.
Myers Industries, Inc. paid $0.14 per share in dividends in Q3 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.
Margins & Returns
Myers Industries, Inc.'s gross margin was 27.3% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is down 3.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 7.0 percentage points.
Myers Industries, Inc.'s operating margin was 8.7% in Q3 2026, reflecting core business profitability. This is down 1.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 8.7 percentage points.
Myers Industries, Inc.'s net profit margin was -0.5% in Q3 2026, showing the share of revenue converted to profit. This is down 5.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 11.7 percentage points.
Myers Industries, Inc.'s quarterly ROE was -0.3% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is down 2.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 6.8 percentage points.
Capital Allocation
Myers Industries, Inc. repurchased no shares in Q3 2026. This represents a decrease of 100.0% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Myers Industries, Inc. invested $5.9M in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 42.3% from the same quarter a year earlier. Against the prior quarter it is up 6.0%.
Not reported for Q3 2026.
MYE Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $171.3M+8.1% | $179.2M+9.8% | $164.6M+1.8% | $342.4M+67.9% | $158.5M-22.7% | $163.2M-25.9% | $161.7M-21.9% | $203.9M+6.7% |
| Cost of Revenue | $124.6M+14.1% | $117.7M+5.0% | $108.0M-3.1% | $216.8M+57.1% | $109.2M-22.0% | $112.2M-22.5% | $111.4M-22.0% | $138.0M+3.1% |
| Gross Profit | $46.8M-5.0% | $61.5M+20.4% | $56.5M+12.6% | $125.5M+90.5% | $49.3M-24.4% | $51.1M-32.4% | $50.2M-21.9% | $65.9M+15.1% |
| SG&A Expenses | $28.4M-1.0% | $26.6M-2.9% | $28.0M-4.4% | $87.1M+96.6% | $28.7M-25.4% | $27.4M-38.0% | $29.3M-37.8% | $44.3M+14.3% |
| Operating Income | $14.8M-11.2% | $31.2M+57.1% | $24.9M+44.5% | $20.8M+42.1% | $16.7Mn/m | $19.8M-16.4% | $17.2M+58.1% | $14.6M-21.3% |
| EBITDA | $18.4M-12.7% | $34.8M+43.4% | $28.6M+31.8% | $25.0M+31.0% | $21.0M+20126.9% | $24.3M-14.9% | $21.7M+46.3% | $19.1M-22.0% |
| Interest Expense | $5.2M-30.7% | $6.3M-14.9% | $6.7M-9.4% | $7.2M-7.6% | $7.5M-7.3% | $7.4M-18.2% | $7.4M+21.5% | $7.8M+464.8% |
| Income Tax | $1.5M-49.8% | $6.2M+115.4% | $4.4M+66.0% | $1.8M-30.6% | $2.9Mn/m | $2.9M-35.7% | $2.6M+102.5% | $2.6M-45.0% |
| Net Income | -$865K-112.2% | $20.0M+106.4% | -$1.8M-126.9% | $11.3M+163.7% | $7.1Mn/m | $9.7M-5.6% | $6.8M+94.3% | $4.3M-65.7% |
| EPS (Basic) | -$0.02-110.5% | $0.53+103.8% | -$0.05-127.8% | $0.30+172.7% | $0.19n/m | $0.26-7.1% | $0.18+100.0% | $0.11-67.6% |
| EPS (Diluted) | -$0.02-110.5% | $0.53+103.8% | -$0.05-127.8% | $0.30+172.7% | $0.19n/m | $0.26-7.1% | $0.18+100.0% | $0.11-67.6% |
| Diluted Shares (Avg) | 38M+0.9% | 38M+1.0% | 38M+0.8% | N/A | 38M+1.0% | 37M+0.3% | 37M+0.8% | N/A |
Not reported in any period shown, so not listed: R&D Expenses.
MYE Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $794.6M-8.0% | $845.0M-2.0% | $836.7M-5.3% | $852.6M-1.0% | $864.1M-4.5% | $862.7M-9.3% | $883.8M-6.7% | $860.8M+58.9% |
| Current Assets | $268.0M-6.5% | $313.5M+13.6% | $300.0M+3.8% | $281.5M+8.5% | $286.8M+4.2% | $276.1M-6.6% | $289.1M+1.9% | $259.3M+1.0% |
| Cash & Equivalents | $53.5M+11.6% | $47.6M+15.4% | $44.6M+26.3% | $40.5M+25.7% | $48.0M+61.4% | $41.3M+10.6% | $35.3M+7.9% | $32.2M+6.4% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Inventory | $73.8M-25.9% | $77.0M-24.5% | $65.3M-37.0% | $67.6M-30.4% | $99.6M-5.2% | $102.0M-3.6% | $103.8M-1.2% | $97.0M+6.8% |
| Accounts Receivable | $108.0M-12.4% | $108.7M-3.6% | $107.0M-18.7% | $95.4M-12.7% | $123.3M+0.4% | $112.8M-13.1% | $131.6M+0.9% | $109.4M-4.0% |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Goodwill | $240.9M-5.8% | $240.9M-5.9% | $241.1M-5.6% | $241.3M-5.6% | $255.9M-8.9% | $256.1M-17.4% | $255.5M-17.6% | $255.5M+167.9% |
| Total Liabilities | $490.5M-15.1% | $538.7M-6.8% | $547.9M-9.7% | $558.4M-4.3% | $577.4M-8.2% | $578.1M-12.0% | $606.4M-7.5% | $583.3M+134.4% |
| Current Liabilities | $141.9M-17.4% | $195.0M+25.2% | $182.3M+12.1% | $169.0M+14.9% | $171.7M+12.0% | $155.7M-4.8% | $162.6M+0.2% | $147.1M-10.9% |
| Non-Current Liabilities | $348.6M-14.1% | $343.7M-18.6% | $365.6M-17.6% | $389.3M-10.7% | $405.7M-14.8% | $422.3M-14.4% | $443.8M-10.0% | $436.2M+421.0% |
| Long-Term Debt | $279.6M-15.7% | $272.4M-21.3% | $291.9M-19.7% | $311.2M-12.4% | $331.7M-9.8% | $346.2M-9.0% | $363.7M-4.5% | $355.3M+1010.7% |
| Total Equity | $304.1M+6.1% | $306.4M+7.6% | $288.9M+4.1% | $294.2M+6.0% | $286.6M+4.0% | $284.6M-3.4% | $277.4M-4.9% | $277.5M-5.2% |
| Retained Earnings | -$32.0Mn/m | -$26.0Mn/m | -$40.9Mn/m | -$33.9Mn/m | -$40.1Mn/m | -$42.1Mn/m | -$46.7Mn/m | -$48.5Mn/m |
MYE Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $17.1M-33.8% | $33.5M+18.5% | $26.2M+158.7% | $22.6M-17.5% | $25.8M+48.7% | $28.3M+97.3% | $10.1M-50.0% | $27.3M+77.6% |
| Depreciation & Amortization | $3.5M-18.3% | $3.7M-17.8% | $3.7M-17.0% | $4.2M-5.4% | $4.3M-11.3% | $4.4M-7.8% | $4.5M+13.7% | $4.5M-24.1% |
| Stock-Based Compensation | $1.4M+75.0% | $1.7M+183.3% | $1.2M+26.7% | N/A | $800K+300.0% | $600Kn/m | $977K+43.3% | N/A |
| Capital Expenditures | $5.9M+42.3% | $5.6M+57.4% | $2.8M-65.5% | $3.8M-47.2% | $4.2M-41.8% | $3.6M-19.4% | $8.0M+41.0% | $7.1M+100.2% |
| Free Cash Flow | $11.1M-48.5% | $27.9M+12.9% | $23.4M+1024.8% | $18.8M-7.0% | $21.6M+112.7% | $24.8M+149.2% | $2.1M-85.7% | $20.2M+70.8% |
| Investing Cash Flow | $17.6Mn/m | -$4.5Mn/m | -$2.6Mn/m | -$3.7Mn/m | -$3.7Mn/m | -$3.5Mn/m | -$8.0Mn/m | -$7.0Mn/m |
| Financing Cash Flow | -$29.2Mn/m | -$25.1Mn/m | -$20.7M-2194.2% | -$21.5Mn/m | -$15.5Mn/m | -$18.5Mn/m | $988K-99.7% | -$17.9Mn/m |
| Dividends Paid | $5.1M+0.4% | $5.2M+2.5% | $5.1M-3.2% | $5.1M+0.3% | $5.1M+0.6% | $5.1M+0.9% | $5.3M-0.5% | $5.0M+1.3% |
| Share Buybacks | $0-100.0% | $0-100.0% | $0-100.0% | $504Kn/m | $506Kn/m | $507Kn/m | $1.0Mn/m | $0 |
MYE Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 27.3%-3.8pp | 34.3%+3.0pp | 34.4%+3.3pp | 36.7%+4.3pp | 31.1%-0.7pp | 31.3%-3.0pp | 31.1%0.0pp | 32.3%+2.4pp |
| Operating Margin | 8.7%-1.9pp | 17.4%+5.2pp | 15.1%+4.5pp | 6.1%-1.1pp | 10.5%+12.9pp | 12.2%+1.4pp | 10.6%+5.4pp | 7.2%-2.6pp |
| Net Margin | -0.5%-5.0pp | 11.2%+5.2pp | -1.1%-5.3pp | 3.3%+1.2pp | 4.5%+9.8pp | 5.9%+1.3pp | 4.2%+2.5pp | 2.1%-4.5pp |
| Return on Equity | -0.3%-2.8pp | 6.5%+3.1pp | -0.6%-3.1pp | 3.9%+2.3pp | 2.5%+6.4pp | 3.4%-0.1pp | 2.5%+1.3pp | 1.6%-2.7pp |
| Return on Assets | -0.1%-0.9pp | 2.4%+1.3pp | -0.2%-1.0pp | 1.3%+0.8pp | 0.8%+2.0pp | 1.1%0.0pp | 0.8%+0.4pp | 0.5%-1.8pp |
| Current Ratio | 1.89+0.2x | 1.61-0.2x | 1.65-0.1x | 1.67-0.1x | 1.67-0.1x | 1.770.0x | 1.780.0x | 1.76+0.2x |
| Debt-to-Equity | 0.92-0.2x | 0.89-0.3x | 1.01-0.3x | 1.06-0.2x | 1.16-0.2x | 1.22-0.1x | 1.310.0x | 1.28+1.2x |
| Liabilities-to-Equity | 1.61-0.4x | 1.76-0.3x | 1.90-0.3x | 1.90-0.2x | 2.01-0.3x | 2.03-0.2x | 2.19-0.1x | 2.10+1.3x |
| Asset Turnover | 0.220.0x | 0.210.0x | 0.200.0x | 0.40+0.2x | 0.180.0x | 0.190.0x | 0.180.0x | 0.24-0.1x |
| FCF Margin | 6.5%-7.1pp | 15.6%+0.4pp | 14.2%+13.0pp | 5.5%-4.4pp | 13.6%+8.7pp | 15.2%+10.7pp | 1.3%-5.7pp | 9.9%+3.7pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Myers Industries, Inc. MYE | FY2025 | $825.7M | $34.9M | 4.2% | $976.7M | 50/100 |
| Trimas Corporation TRS | FY2025 | $645.7M | $120.1M | 18.6% | $1.3B | 44/100 |
| O-I Glass, Inc. OI | FY2025 | $6.4B | -$129.0M | -2.0% | $648.1M | 27/100 |
| Karat Packaging Inc. KRT | FY2025 | $467.7M | $31.5M | 6.7% | $591.9M | 63/100 |
| Graphic Packaging Holding Company GPK | FY2025 | $8.6B | $444.0M | 5.1% | $3.0B | 43/100 |
| Greif, Inc. GEF | FY2026 | $4.4B | $258.5M | 5.9% | $3.6B | 42/100 |
Where Myers Industries, Inc. Ranks
Frequently Asked Questions
Myers Industries, Inc. (MYE) reported $825.7M in total revenue for fiscal year 2025. This represents a -1.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Myers Industries, Inc. (MYE) revenue declined by 1.3% year-over-year, from $836.3M to $825.7M in fiscal year 2025.
Yes, Myers Industries, Inc. (MYE) reported a net income of $28.7M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $34.9M, with a net profit margin of 4.2%.
Myers Industries, Inc. (MYE) had EBITDA of $92.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2025, Myers Industries, Inc. (MYE) had $40.5M in cash and equivalents against $311.2M in long-term debt.
Myers Industries, Inc. (MYE) had a gross margin of 33.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
Myers Industries, Inc. (MYE) had an operating margin of 9.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
Myers Industries, Inc. (MYE) had a net profit margin of 4.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Yes, Myers Industries, Inc. (MYE) paid $0.54 per share in dividends during fiscal year 2025.
Myers Industries, Inc. (MYE) has a return on equity of 11.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
Myers Industries, Inc. (MYE) generated $67.2M in free cash flow during fiscal year 2025. This represents a 22.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Myers Industries, Inc. (MYE) generated $86.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
Myers Industries, Inc. (MYE) had $852.6M in total assets as of fiscal year 2025, including both current and long-term assets.
Myers Industries, Inc. (MYE) invested $19.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
Myers Industries, Inc. (MYE) had a current ratio of 1.67 as of fiscal year 2025, which is generally considered healthy.
Myers Industries, Inc. (MYE) had a debt-to-equity ratio of 1.06 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
Myers Industries, Inc. (MYE) had a liabilities-to-equity ratio of 1.90 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
Myers Industries, Inc. (MYE) had a return on assets of 4.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Myers Industries, Inc. (MYE) trades at 34.1x earnings, its market capitalization divided by $28.7M net income, trailing 12 months to September 30, 2026. The market capitalization is $976.7M as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Myers Industries, Inc. (MYE) trades at 1.1x sales, its market capitalization divided by $857.5M revenue, trailing 12 months to September 30, 2026. The market capitalization is $976.7M as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Myers Industries, Inc. (MYE) has an Altman Z-Score of 2.41, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
Myers Industries, Inc. (MYE) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Myers Industries, Inc. (MYE) has an earnings quality ratio of 2.48x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Myers Industries, Inc. (MYE) has an interest coverage ratio of 2.53x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
Myers Industries, Inc. (MYE) scores 50 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.